首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1542532

全球 HLA 打字市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global HLA Typing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2032 年，全球 HLA 分型市場的市場規模將從 2023 年的 575 萬美元達到近 1,411 萬美元，2024-2032 年研究期間複合年成長率為 10.5%。

HLA 分型或人類白血球抗原分型是一種用於識別細胞表面特定蛋白質的過程，這些蛋白質對於免疫系統識別外來物質的能力至關重要。這些蛋白質由主要組織相容性複合體 (MHC) 內的基因編碼，幫助免疫系統區分自身細胞和非自身細胞。它在包括器官移植在內的各種醫療環境中都很重要，其中匹配捐贈者和接受者的 HLA 圖譜可以降低排斥風險。它也用於輸血和疾病關聯研究，有助於自體免疫疾病和某些癌症的診斷和治療。

市場動態

HLA 分型市場正在受到塑造醫學診斷和移植醫學格局的幾個關鍵因素的推動。自體免疫疾病、傳染病和血液惡性腫瘤的盛行率不斷增加，需要準確可靠的 HLA 分型來進行疾病診斷、預後和治療選擇。此外，由於人口老化和慢性病的流行，對器官和組織移植的需求不斷成長，這也加劇了對器官和組織移植過程的需求，以匹配捐贈者和受者並最大限度地降低排斥風險。此外，NGS、聚合酶鍊式反應和序列特異性寡核苷酸探針(SSOP) 等HLA 分型技術的進步提高了這些檢測的準確性、速度和可擴展性，從而實現了高解析度分型和等位基因識別。此外，在臨床指南和監管標準的支持下，它融入常規臨床實踐和移植管理協議，推動了打字服務在全球醫療保健機構中的採用和利用。此外，增加研發投資以擴大其在個人化醫療、藥物基因組學和免疫分析方面的應用，有助於該技術和服務的市場成長和創新。此外，醫療保健組織、診斷實驗室和技術提供者之間的策略合作和夥伴關係促進了新型 HLA 分型解決方案的開發和商業化，並擴大了市場範圍。然而，嚴格的監管要求和程序的複雜性可能會阻礙該市場未來幾年的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球 HLA 分型市場的各個細分市場進行了包容性評估。 HLA 分型產業的成長和趨勢為本研究提供了整體方法。

市場區隔

HLA 打字市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

儀器儀表
試劑及耗材
軟體與服務

按申請

診斷
研究

依技術

分子檢測
基於定序的分子測定
非分子檢測

按最終用戶

商業服務提供者
醫院及移植中心
研究實驗室和學術機構

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的 HLA 分型市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。 HLA 分型市場的主要參與者包括 Thermo Fisher Scientific Inc.、Bio-Rad Laboratories Inc.、Qiagen NV、Omixon Inc.、GenDx、Illumina Inc.、TBG Diagnostics Limited、Dickinson and Company、Takara Bio Inc.、F.霍夫曼-拉羅氏有限公司、太平洋生物科學公司。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按產品分類的市場吸引力分析
- 市場吸引力分析：依應用分類
- 按技術分類的市場吸引力分析
- 最終用戶的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球 HLA 分型市場分析：依產品

按產品概述
歷史和預測數據
按產品分析
儀器儀表
試劑及耗材
軟體與服務

第 6 章：全球 HLA 分型市場分析：依應用分類

概述：按應用
歷史和預測數據
分析：按應用
診斷
研究

第 7 章：全球 HLA 分型市場分析：依技術分類

依技術概述
歷史和預測數據
技術分析
分子檢測
基於定序的分子測定
非分子檢測

第 8 章：全球 HLA 分型市場分析：依最終使用者分類

最終用戶概述
歷史和預測數據
最終用戶分析
商業服務提供者
醫院及移植中心
研究實驗室和學術機構

第 9 章：全球 HLA 分型市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：HLA 打字公司的競爭格局

Hla 打字市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

公司股份分析
市場集中度
Thermo Fisher Scientific Inc.

公司概況
公司收入
產品
最新動態

Bio-Rad Laboratories Inc.

公司概況
公司收入
產品
最新動態

Qiagen NV

公司概況
公司收入
產品
最新動態

Omixon Inc.

公司概況
公司收入
產品
最新動態

GenDx

公司概況
公司收入
產品
最新動態

Illumina Inc.

公司概況
公司收入
產品
最新動態

TBG Diagnostics Limited

公司概況
公司收入
產品
最新動態

Dickinson and Company

公司概況
公司收入
產品
最新動態

Takara Bio Inc.

公司概況
公司收入
產品
最新動態

F. Hoffman-La Roche Limited

公司概況
公司收入
產品
最新動態

Pacific Biosciences

公司概況
公司收入
產品
最新動態

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112110056

The global demand for HLA Typing Market is presumed to reach the market size of nearly USD 14.11 Million by 2032 from USD 5.75 Million in 2023 with a CAGR of 10.5% under the study period 2024 - 2032.

HLA typing, or human leukocyte antigen typing, is a process used to identify specific proteins on the surface of cells that are crucial in the immune system's ability to recognize foreign substances. These proteins, encoded by genes within the major histocompatibility complex (MHC), help the immune system distinguish between self and non-self cells. It is important in various medical contexts, including organ transplantation, where matching the HLA profiles of donors and recipients reduces rejection risks. It is also used in blood transfusions and disease association studies, aiding in the diagnosis and treatment of autoimmune diseases and certain cancers.

MARKET DYNAMICS

The HLA typing market is being propelled by several key factors shaping the landscape of medical diagnostics and transplantation medicine. The increasing prevalence of autoimmune diseases, infectious diseases, and hematological malignancies necessitates accurate and reliable HLA typing for disease diagnosis, prognosis, and treatment selection. Additionally, the rising demand for organ and tissue transplantation, driven by the growing aging population and the prevalence of chronic diseases, fuels the need for this process to match donors and recipients and minimize the risk of rejection. Moreover, advancements in HLA typing technologies, such as NGS, polymerase chain reaction, and sequence-specific oligonucleotide probes (SSOP), enhance the accuracy, speed, and scalability of these assays, enabling high-resolution typing and allele identification. Furthermore, its integration into routine clinical practice and transplant management protocols, supported by clinical guidelines and regulatory standards, drives the adoption and utilization of typing services in healthcare settings worldwide. Additionally, increasing investments in research and development to expand its applications in personalized medicine, pharmacogenomics, and immune profiling contribute to market growth and innovation in this technology and service. Furthermore, strategic collaborations and partnerships among healthcare organizations, diagnostic laboratories, and technology providers facilitate the development and commercialization of novel HLA typing solutions and expand market reach. However, stringent regulatory requirements and the complexity of the procedures may hinder the growth of this market in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain Analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of HLA typing. The growth and trends of HLA typing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the hla typing market report provides detailed data on the segments at the country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Instruments
Reagents & Consumables
Software & Services

By Application

Diagnosis
Research

By Technique

Molecular Assay
Sequenced-Based Molecular Assay
Non-Molecular Assay

By End-User

Commercial Service Providers
Hospitals And Transplant Centers
Research Labs & Academic Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the HLA Typing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the HLA typing market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Omixon Inc., GenDx, Illumina Inc., TBG Diagnostics Limited, Dickinson and Company, Takara Bio Inc., F. Hoffman-La Roche Limited, Pacific Biosciences. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . HLA TYPING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Technique
- 3.7.4 Market Attractiveness Analysis By End-User
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL HLA TYPING MARKET ANALYSIS BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 Instruments Historic and Forecast Sales by Regions
5.5 Reagents & Consumables Historic and Forecast Sales by Regions
5.6 Software & Services Historic and Forecast Sales by Regions

6 . GLOBAL HLA TYPING MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Diagnosis Historic and Forecast Sales by Regions
6.5 Research Historic and Forecast Sales by Regions

7 . GLOBAL HLA TYPING MARKET ANALYSIS BY TECHNIQUE

7.1 Overview by Technique
7.2 Historical and Forecast Data
7.3 Analysis by Technique
7.4 Molecular Assay Historic and Forecast Sales by Regions
7.5 Sequenced-Based Molecular Assay Historic and Forecast Sales by Regions
7.6 Non-Molecular Assay Historic and Forecast Sales by Regions

8 . GLOBAL HLA TYPING MARKET ANALYSIS BY END-USER

8.1 Overview by End-User
8.2 Historical and Forecast Data
8.3 Analysis by End-User
8.4 Commercial Service Providers Historic and Forecast Sales by Regions
8.5 Hospitals And Transplant Centers Historic and Forecast Sales by Regions
8.6 Research Labs & Academic Institutes Historic and Forecast Sales by Regions

9 . GLOBAL HLA TYPING MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. South East Asia Sales Analysis
- 9.5.10. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE HLA TYPING COMPANIES

10.1. Hla Typing Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF HLA TYPING INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Thermo Fisher Scientific Inc.
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Bio-Rad Laboratories Inc.
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Qiagen N.V.
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Omixon Inc.
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. GenDx
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Illumina Inc.
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. TBG Diagnostics Limited
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Dickinson and Company
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Takara Bio Inc.
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. F. Hoffman-La Roche Limited
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. Pacific Biosciences
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments